Kolkata, West Bengal -- (SBWIRE) -- 09/27/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Halozyme Therapeutics, Inc. (NASDAQ:HALO), Dyax Corp. (NASDAQ:DYAX).
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares climbed 8.41% to $10.57. The company, on Sept. 26, announced that the commercial launch of Herceptin® SC in Europe has triggered a $10 million milestone payment to Halozyme under the License and Collaboration Agreement between Halozyme and Roche. This time-saving subcutaneous formulation of Herceptin (trastuzumab) using Halozyme's recombinant human hyaluronidase (rHuPH20) received marketing authorization from the European Commission on August 28, 2013 for the treatment of patients with HER2-positive breast cancer and was launched upon approval. Herceptin SC reduces treatment times and enhances convenience compared to the standard intravenous (IV) form.
Should Investors Buy HALO After Yesterday’s Jump? Find Out Here
Dyax Corp. (NASDAQ:DYAX) shares increased 11.06% to $6.73. Leerink Swann maintained an Outperform rating on Dyax Corp. (NASDAQ: DYAX) and raised its price target to $7.00 (from $5.00) on Sept. 16. Analyst Joseph P. Schwartz sees increased value in DX2930.
Additionally, the company participated in the Morgan Stanley Global Healthcare Conference, being held September 9-11, 2013 at the Grand Hyatt in New York City.
How Should Investors Trade DYAX After The Recent Volatility? Get Free Trend Analysis Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)